YORK, Pa., June 18, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), a U.S. based designer, developer and manufacturer of injectable drug delivery systems, today announced the launch of its new corporate website at www.unilife.com. The new site includes additional products, videos, features, blogs and other information, with updates to occur on a regular basis.
Mr. Alan Shortall, the CEO of Unilife, stated, "As an emerging global leader for injectable drug delivery systems, we have created an elegant website that reflects our unique ability to address customer needs with speed, agility and reliability. We believe all of the Company's stakeholders will benefit from the added features available through the new site.
"The Unilife website provides existing and potential pharmaceutical customers with a clear, comprehensive view of our broad portfolio of injectable drug delivery systems and capabilities to showcase how we can enhance and differentiate their injectable therapies. As with our game-changing, highly differentiated products, we believe the Unilife website sets a new benchmark for our industry," Mr. Shortall concluded.
Those wishing to receive breaking news on Unilife are encouraged to subscribe to email alerts at http://ir.unilife.com/alerts.cfm.
About Unilife Corporation
Unilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's broad portfolio of proprietary device technologies includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors and targeted delivery systems. Each of these innovative and highly differentiated device platforms can be customized by Unilife to address specific customer, drug and patient requirements. Unilife's global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information, please visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.
General: UNIS-G Investor Contacts (US):
Media ContactTodd Fromer / Garth Russell
Eve McGrathKCSA Strategic Communications
Rubenstein PRP: + 1 212-682-6300
P: + 1 415-202-5678
P: + 61 2 8346 6500
P: + 1 212 843-8490
|SOURCE Unilife Corporation|
Copyright©2012 PR Newswire.
All rights reserved